First-in-Human Study of ADEL-Y01, a Monoclonal Antibody Targeting Acetylated Tau (acK280) in the MTBR: Safety and Pharmacokinetics in Healthy Adults and Early Alzheimer&#39;s Disease

ADEL-Y01 - Oscotec, ADEL

https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/Final%20Program%20CTAD%202025_Dec1st_App.pdf

Min-Seok Kim 1,2; Yuna Oh 1; Sungsil Lee 3; Kyung-Hoon Hwang 1; Young-Soo Sohn 1; Dong-Sik Jung 3; Taeyoung Yoon 3; Peter J. Winkle 4; Seung-Yong Yoon 1,2

Dec 14, 2025